SpringWorks Therapeutics, Inc. (SWTX)
Jul 1, 2025 - SWTX was delisted (reason: acquired by Merck KGaA)
46.99
0.00 (0.00%)
Inactive · Last trade price
on Jun 30, 2025
SpringWorks Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Operating Revenue | 200.12 | 172.04 | 5.45 | - | - | 35 | Upgrade
|
| Other Revenue | 19.55 | 19.55 | - | - | - | - | Upgrade
|
| Revenue | 219.67 | 191.59 | 5.45 | - | - | 35 | Upgrade
|
| Revenue Growth (YoY) | 730.42% | 3417.33% | - | - | - | - | Upgrade
|
| Cost of Revenue | 14.88 | 12.55 | 0.42 | - | - | - | Upgrade
|
| Gross Profit | 204.8 | 179.04 | 5.03 | - | - | 35 | Upgrade
|
| Selling, General & Admin | 273.04 | 256.65 | 197.55 | 134.55 | 71.79 | 29.47 | Upgrade
|
| Research & Development | 196.49 | 200.52 | 150.49 | 146.12 | 101.68 | 51.86 | Upgrade
|
| Operating Expenses | 469.53 | 457.17 | 348.04 | 280.67 | 173.47 | 81.32 | Upgrade
|
| Operating Income | -264.74 | -278.13 | -343.01 | -280.67 | -173.47 | -46.32 | Upgrade
|
| Interest & Investment Income | 18.43 | 26 | 22.95 | 6.15 | 0.55 | 1.33 | Upgrade
|
| Earnings From Equity Investments | -6.63 | -6 | -5.04 | -2.89 | -0.99 | -0.61 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | 0.03 | Upgrade
|
| Pretax Income | -253.93 | -258.13 | -325.1 | -277.42 | -173.91 | -45.57 | Upgrade
|
| Net Income | -253.93 | -258.13 | -325.1 | -277.42 | -173.91 | -45.57 | Upgrade
|
| Net Income to Common | -253.93 | -258.13 | -325.1 | -277.42 | -173.91 | -45.57 | Upgrade
|
| Shares Outstanding (Basic) | 74 | 74 | 63 | 53 | 48 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 74 | 74 | 63 | 53 | 48 | 43 | Upgrade
|
| Shares Change (YoY) | 12.77% | 17.44% | 18.45% | 9.88% | 12.00% | 226.18% | Upgrade
|
| EPS (Basic) | -3.41 | -3.48 | -5.15 | -5.21 | -3.59 | -1.05 | Upgrade
|
| EPS (Diluted) | -3.41 | -3.48 | -5.15 | -5.21 | -3.59 | -1.05 | Upgrade
|
| Free Cash Flow | -169.33 | -180.05 | -230.18 | -171.76 | -129.89 | -32.83 | Upgrade
|
| Free Cash Flow Per Share | -2.28 | -2.43 | -3.65 | -3.22 | -2.68 | -0.76 | Upgrade
|
| Gross Margin | 93.23% | 93.45% | 92.25% | - | - | 100.00% | Upgrade
|
| Operating Margin | -120.52% | -145.17% | -6297.28% | - | - | -132.35% | Upgrade
|
| Profit Margin | -115.60% | -134.73% | -5968.50% | - | - | -130.21% | Upgrade
|
| Free Cash Flow Margin | -77.09% | -93.98% | -4225.81% | - | - | -93.81% | Upgrade
|
| EBITDA | -260.9 | -274.66 | -341.35 | -279.91 | -172.98 | -45.98 | Upgrade
|
| EBITDA Margin | -118.77% | -143.36% | - | - | - | -131.36% | Upgrade
|
| D&A For EBITDA | 3.84 | 3.47 | 1.67 | 0.77 | 0.49 | 0.35 | Upgrade
|
| EBIT | -264.74 | -278.13 | -343.01 | -280.67 | -173.47 | -46.32 | Upgrade
|
| EBIT Margin | -120.52% | -145.17% | - | - | - | -132.35% | Upgrade
|
| Revenue as Reported | 219.67 | 191.59 | 5.45 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.